The impact of ureteral stent type on patient symptoms as determined by the ureteral stent symptom questionnaire: A prospective, randomized, controlled study

Journal of Endourology

Volumn 29, Issue 3, 2015, Pages 367-371

  Park, Hyoung Keun ^a   Paick, Sung Hyun ^a   Kim, Hyeong Gon ^a   Lho, Yong Soo ^a   Bae, Sangrak ^b  

^a Konkuk University School of Medicine   (South Korea)

^b Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; ASSESSMENT OF HUMANS; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REST; SEX RATIO; SEXUAL BEHAVIOR; URETER STENT; URETERAL STENT SYMPTOM QUESTIONNAIRE; URETEROSCOPY; VISUAL ANALOG SCALE; AGED; COMPARATIVE STUDY; MIDDLE AGED; PAIN MEASUREMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL DYSFUNCTION; STENT; URETER; URINARY CALCULI; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; STENTS; URETER; URETEROSCOPY; URINARY CALCULI; YOUNG ADULT;

EID: 84924212050     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2014.0294     Document Type: Article

References (50)

1. Liatsikos E, Kallidonis P, Stolzenburg J-U, Karnabatidis D. Ureteral stents: Past, present and future. Expert Rev Med Devices 2009;6:313-324.
2. Erturk E, Sessions A, Joseph JV. Impact of ureteral stent diameter on symptoms and tolerability. J Endourol 2003; 17:59-62.
3. Joshi H, Stainthorpe A, MacDonagh R, et al. Indwelling ureteral stents: Evaluation of symptoms, quality of life and utility. J Urol 2003;169:1065-1069.
4. Miyaoka R, Monga M. Ureteral stent discomfort. Etiology and management. Indian J Urol 2009;25:455-460.
5. Sighinolfi M, Micali S, De Stefani S, et al. Indwelling ureteral stents and sexual health: A prospective, multivariate analysis. J Urol 2007;178:229-231.
6. Beddingfield R, Pedro RN, Hinck B, et al. Alfuzosin to relieve ureteral stent discomfort: A prospective, randomized, placebo controlled study. J Urol 2009;181:170-176.
7. Damiano R, Autorino R, De Sio M, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 2005;48:673-678.
8. Damiano R, Autorino R, De Sio M, et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: A prospective study. J Endourol 2008;22:651-656.
9. Deliveliotis C, Chrisofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006;67:35-39.
10. Dellis A, Joshi HB, Timoney AG, Keeley FX Jr. Relief of stent related symptoms: Review of engineering and pharmacological solutions. J Urol 2010;184:1267-1272.
11. Ho CH, Chen SC, Chung SD, et al. Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol 2008;22:1427-1431.
12. Krambeck AE, Walsh RS, Denstedt JD, et al. A novel drug eluting ureteral stent: A prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol 2010;183:1037-1042.
13. Lamb AD, Vowler SL, Johnston R, et al. Meta-Analysis showing the beneficial effect of a-blockers on ureteric stent discomfort. BJU Int 2011;108:1894-1902.
14. Lim KT, Kim YT, Lee TY, Park SY. Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 2011;52: 485-488.
15. Navanimitkul N, Lojanapiwat B. Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: A randomized controlled study. J Int Med Res 2010;38:1436-1441.
16. Rane A, Saleemi A, Cahill D, et al. Have stent-related symptoms anything to do with placement technique? J Endourol 2001;15:741-745.
17. Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J Endourol 1993;7:137-140.
18. Yakoubi R, Lemdani M, Monga M, et al. Is there a role for a-blockers in ureteral stent related symptoms? A systematic review and meta-Analysis. J Urol 2011;186:928-934.
19. Sanguedolce F, Millan-Rodriquez F, Santillana-Altimira JM, et al. The Spanish linguistic validation of the Ureteral Stent Symptom Questionnaire. J Endourol 2014;28:237-242.
20. Puichaud A, Larré S, Bruyère F, et al. [The French linguistic validation of the Ureteric Stent Symptom Questionnaire (USSQ).] (Fre) Prog Urol 2010;20:210-213.
21. Park J, Shin DW, You C, et al. Cross-cultural application of the Korean version of Ureteral Stent Symptoms Questionnaire. J Endourol 2012;26:1518-1522.
22. Giannarini G, Keeley FX, Valent F, et al. The Italian linguistic validation of the Ureteral Stent Symptoms Questionnaire. J Urol 2008;180:624-628.
23. Joshi H, Okeke A, Newns N, et al. Characterization of urinary symptoms in patients with ureteral stents. Urology 2002;59:511-516.
24. Leibovici D, Cooper A, Lindner A, et al. Ureteral stents: Morbidity and impact on quality of life. Isr Med Assoc J 2005;7:491-494.
25. Davenport K, Kumar V, Collins J, et al. New ureteral stent design does not improve patient quality of life: A randomized, controlled trial. J Urol 2011;185:175-178.
26. Liatsikos E, Kallidonis P, Stolzenburg J-U, Karnabatidis D. Ureteral stents: Past, present and future. Expert Rev Med Devices 2009;6:313-324.
27. Erturk E, Sessions A, Joseph JV. Impact of ureteral stent diameter on symptoms and tolerability. J Endourol 2003; 17:59-62.
28. Joshi H, Stainthorpe A, MacDonagh R, et al. Indwelling ureteral stents: Evaluation of symptoms, quality of life and utility. J Urol 2003;169:1065-1069.
29. Miyaoka R, Monga M. Ureteral stent discomfort. Etiology and management. Indian J Urol 2009;25:455-460.
30. Sighinolfi M, Micali S, De Stefani S, et al. Indwelling ureteral stents and sexual health: A prospective, multivariate analysis. J Urol 2007;178:229-231.
31. Beddingfield R, Pedro RN, Hinck B, et al. Alfuzosin to relieve ureteral stent discomfort: A prospective, randomized, placebo controlled study. J Urol 2009;181:170-176.
32. Damiano R, Autorino R, De Sio M, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 2005;48:673-678.
33. Damiano R, Autorino R, De Sio M, et al. Effect of tamsulosin in preventing ureteral stent-related morbidity: A prospective study. J Endourol 2008;22:651-656.
34. Deliveliotis C, Chrisofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006;67:35-39.
35. Dellis A, Joshi HB, Timoney AG, Keeley FX Jr. Relief of stent related symptoms: Review of engineering and pharmacological solutions. J Urol 2010;184:1267-1272.
36. Ho CH, Chen SC, Chung SD, et al. Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol 2008;22:1427-1431.
37. Krambeck AE, Walsh RS, Denstedt JD, et al. A novel drug eluting ureteral stent: A prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol 2010;183:1037-1042.
38. Lamb AD, Vowler SL, Johnston R, et al. Meta-Analysis showing the beneficial effect of a-blockers on ureteric stent discomfort. BJU Int 2011;108:1894-1902.
39. Lim KT, Kim YT, Lee TY, Park SY. Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 2011;52: 485-488.
40. Navanimitkul N, Lojanapiwat B. Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: A randomized controlled study. J Int Med Res 2010;38:1436-1441.
41. Rane A, Saleemi A, Cahill D, et al. Have stent-related symptoms anything to do with placement technique? J Endourol 2001;15:741-745.
42. Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J Endourol 1993;7:137-140.
43. Yakoubi R, Lemdani M, Monga M, et al. Is there a role for a-blockers in ureteral stent related symptoms? A systematic review and meta-Analysis. J Urol 2011;186:928-934.
44. Sanguedolce F, Millan-Rodriquez F, Santillana-Altimira JM, et al. The Spanish linguistic validation of the Ureteral Stent Symptom Questionnaire. J Endourol 2014;28:237-242.
45. Puichaud A, Larré S, Bruyère F, et al. [The French linguistic validation of the Ureteric Stent Symptom Questionnaire (USSQ).] (Fre) Prog Urol 2010;20:210-213.
46. Park J, Shin DW, You C, et al. Cross-cultural application of the Korean version of Ureteral Stent Symptoms Questionnaire. J Endourol 2012;26:1518-1522.
47. Giannarini G, Keeley FX, Valent F, et al. The Italian linguistic validation of the Ureteral Stent Symptoms Questionnaire. J Urol 2008;180:624-628.
48. Joshi H, Okeke A, Newns N, et al. Characterization of urinary symptoms in patients with ureteral stents. Urology 2002;59:511-516.
49. Leibovici D, Cooper A, Lindner A, et al. Ureteral stents: Morbidity and impact on quality of life. Isr Med Assoc J 2005;7:491-494.
50. Davenport K, Kumar V, Collins J, et al. New ureteral stent design does not improve patient quality of life: A randomized, controlled trial. J Urol 2011;185:175-178.